Michel Detheux has succeeded Rita Balice-Gordon as CEO of Danish neuro biotech Muna Therapeutics.
July 2, 2026 07:00 AM EDT
Peer Review
Ex-iTeos CEO starts fresh at GSK neuro partner; Genentech loses yet another key scientist
Alex Hoffman
Copy Chief and News Editor
Le Belge Michel Detheux, ex-patron d’Iteos Therapeutics, la biotech aujourd’hui disparue, prend la tête de Muna Therapeutics. Une…
Thomas Lampron formally announced on LinkedIn this week that he is 'thrilled to join the powerhouse team at Revolution Medicines'…
Immunic (IMUX) stock rises premarket to $13.14 as the company names former Genentech executive Erik Lundgren as CEO. See how his…
MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances…
Valerio Therapeutics Appoints Gilles Besin as Chief Executive Officer and Announces Results of its Annual General Meeting
Houman Ashrafian is leaving Sanofi to pursue a new opportunity. Elsewhere, one of Merck’s prized immune drugs succeeded in a…
